Tioga Pharmaceuticals, Inc.

Tioga Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2005 in San Diego, California, initially focused on GI diseases and now on non-hormonal women's health. Develops asimadoline, a selective kappa-opioid receptor agonist, for D-IBS and atopic pruritus. Raised $52M in funding.